AHA is proud to introduce a new program to further science collaboration hosted by Dr. Elliot Antman: The AHA Emerging Science™ Series webinars are one hour professional quality webinars held three times per year. Dr. Antman will host each webinar, which will have two 30 minute blocks, consisting of presentations of original research from the following categories:
Submit To AHA's Emerging Science™ Series!
AHA's Emerging Science™ Series is accepting submissions until May 9, 2012, 5 p.m. CDT (UTC -05).
http://scientificsessions.org/emergingscience
For learning objectives and submission guidelines, please click these links:
ESS Learning Objectives & ESS Science Submission Guidelines
Protecting Cerebrovascular Function- From Translational
Science to Clinical Trials
| Moderators: | Robert O Bonow, Elliott Antman and Robert Harrington |
|
| Panelists: | Jeffrey Weitz, John M Murkin and Mark Clay |
|
| Presentation: |
Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial |
Jonathan P Piccini, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC |
|
|
Discussion Q&A |
|
|
Presentation: |
Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery |
Ronald B Easley, Baylor Coll of Med, Houston, TX |
|
|
Discussion Q&A |
|
Questions or Comments?
|
Abstract Submission Email: support@abstractsonline.com Phone: 217-398-1792 |
General Information Email: sessions@heart.org Online: scientificsessions.org |
Categories
Search Blogs
Comment Using Social Media - Facebook, Yahoo, Hotmail
on http://networking.americanheart.org/blogs/43/399